- AAOI’s AI data-center revenue rose 254% year over year to $155.6 million; Q3 produced its first recent GAAP profit, $6.3 million.
- Management guides to $385–420 million of Q4 revenue and $46–60 million of adjusted profit, but sustaining that pace requires factory expansion and continued AI demand.
- The turnaround consumed $469 million in trailing-twelve-month capex, about $601 million of negative free cash flow, and substantial dilution; share count approaches 96 million.
- The author calls AAOI a high-risk turnaround, not fundamentally solid: a conservative entry is $33, while positive free cash flow, another GAAP profit, and stabilizing share count would change the view.
Investment pitches
filter:
79 75 - MRVL closed at $133.55, about 60% below its high and ~16x Morningstar’s FY2028 adjusted-earnings forecast; the author prefers $112–120, or $100 conservatively, versus Morningstar’s $326 fair value.
- Custom AI chips and optical links drive the thesis: management targets custom-chip revenue doubling in FY2028 and again to ~$10bn in FY2029; Morningstar expects optics to grow ~60% annually, alongside a $70–90bn FY2031 revenue target versus $8.2bn in 2025.
- AI spending is the key dependency; customer concentration, larger rivals, geopolitics, and dilution add risk. Morningstar calls the all-stock Lumentum purchase overpriced, cutting fair value from $360 to $326.
83 - BE monetizes a grid bottleneck: on-site fuel-cell plants can power AI data centers in months, not years, helping revenue reach $3.83B LTM from $2.0B in 2025.
- A $6.0B backlog, up 140% year over year, and 2026 guidance raised from $3.2B to $4.5B support growth; gas turbines could erase Bloom’s speed premium.
- Fundamentals remain unproven: September receivables reached $1.47B, Morningstar models $530M negative 2026 FCF, and $167.52 is 64% above its $102 fair value.
- After a reported 15% bounce, the author’s $150–166 technical buy zone targets $360; a close below $113 invalidates the setup and points toward ~$80.
62 - Nebius has roughly $44bn of signed Microsoft and Meta contracts versus $530m of 2025 revenue, creating exceptional forward growth but demanding execution.
- The economics hinge on utilization: Morningstar estimates 20%–30% annual GPU returns above 80% occupancy, but says returns collapse around 60%–65%.
- Morningstar’s $150 fair value is near $141.52, while projected cash burn of roughly $30bn could increase diluted shares from 243m to 400m by 2027.
- The author would buy for the long term now, targeting $300 on a 12–18-month recovery; a post-earnings pullback toward $90 could offer a better entry.
76 - At roughly $50, CRWV trades at ~46% of Wall Street’s $108 fair-value estimate; the author sees a leveraged AI-infrastructure opportunity, not a safe compounder.
- Revenue rose from $229m in 2023 to $7.59bn TTM; a $104bn backlog plus $25bn added, with ~98% take-or-pay contracts, could provide substantial revenue visibility.
- The buildout consumes capital: TTM capex was $20.6bn and FCF -$13.7bn; June 2026 debt totaled ~$35.1bn against $5.5bn cash, with debt forecast near $40bn by year-end.
- The author sees a high-risk, asymmetric setup: a demand zone targets ~$190 versus <$30 invalidation (~6.5:1); a ~$17m March 2027 $85 options order adds interest, but execution, demand and deleveraging must hold.
67 - BE has risen over 2,318% in 700 days, but the monthly BX Trender is turning red; October’s close and upcoming earnings could still extend the cycle.
- Weekly structure remains bullish after a bounce near $160, while daily structure is bullish with a $197.50 swing low and $302.35 swing high.
- The setup qualifies as a buy under the author’s strategy, but the author is staying out after missing prior breakouts and viewing entry as late.
- Targets are $300 over 30 days and $360 or a new high over 60 days; a break below $197.50 could trigger a 20% move back toward $160.